首页> 外文期刊>Drug safety: An international journal of medical toxicology and drug experience >Prevalence and Nature of Medication Errors and Preventable Adverse Drug Events in Paediatric and Neonatal Intensive Care Settings: A Systematic Review
【24h】

Prevalence and Nature of Medication Errors and Preventable Adverse Drug Events in Paediatric and Neonatal Intensive Care Settings: A Systematic Review

机译:儿科和新生儿重症监护环境中药物误差和可预防不良药物事件的患病率和性质:系统评价

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction Children admitted to paediatric and neonatal intensive care units may be at high risk from medication errors and preventable adverse drug events. Objective The objective of this systematic review was to review empirical studies examining the prevalence and nature of medication errors and preventable adverse drug events in paediatric and neonatal intensive care units. Data Sources Seven electronic databases were searched between January 2000 and March 2019. Study Selection Quantitative studies that examined medication errors/preventable adverse drug events using direct observation, medication chart review, or a mixture of methods in children <= 18 years of age admitted to paediatric or neonatal intensive care units were included. Data Extraction Data on study design, detection method used, rates and types of medication errors/preventable adverse drug events, and medication classes involved were extracted. Results Thirty-five unique studies were identified for inclusion. In paediatric intensive care units, the median rate of medication errors was 14.6 per 100 medication orders (interquartile range 5.7-48.8%, n = 3) and between 6.4 and 9.1 per 1000 patient-days (n = 2). In neonatal intensive care units, medication error rates ranged from 4 to 35.1 per 1000 patient-days (n = 2) and from 5.5 to 77.9 per 100 medication orders (n = 2). In both settings, prescribing and medication administration errors were found to be the most common medication errors, with dosing errors the most frequently reported error subtype. Preventable adverse drug event rates were reported in three paediatric intensive care unit studies as 2.3 per 100 patients (n = 1) and 21-29 per 1000 patient-days (n = 2). In neonatal intensive care units, preventable adverse drug event rates from three studies were 0.86 per 1000 doses (n = 1) and 0.47-14.38 per 1000 patient-days (n = 2). Anti-infective agents were commonly involved with medication errors/preventable adverse drug events in both settings. Conclusions Medication errors occur frequently in critically ill children admitted to paediatric and neonatal intensive care units and may lead to patient harm. Important targets such as dosing errors and anti-infective medications were identified to guide the development of remedial interventions.
机译:引入儿童和新生儿重症监护单位的儿童可能患上药物误差和可预防的不良药物事件的风险。发明内容对系统审查的目的是审查检测药物误差患病率和性质的实证研究,以及预防儿科和新生儿重症监护单位的药物患者。在2019年1月和2019年3月期间搜查了数据来源七个电子数据库。研究选择使用直接观察,药物图表评论或儿童方法的混合物检查药物错误/可预防的不良药物事件的定量研究<= 18岁包括儿科或新生儿重症监护单位。提取数据提取数据,使用的检测方法,药物误差/可预防的不良药物事件和所涉及的药物类别。结果鉴定了三十五项独特的研究纳入。在儿科重症监护单位中,药物误差的中值率为每100药物订单(5.7-48.8%,n = 3),每1000例患者天(n = 2)为6.4和9.1。在新生儿重症监护单位中,药物误差率从每1000例患者(n = 2)的4至35.1次,每100个药物订单(n = 2)为5.5至77.9。在两个设置中,发现处方和药物管理误差是最常见的药物误差,具有给药错误最常见的错误亚型。在三个儿科重症监护病例研究中报告了预防的不良药物事件率,为每100名患者每100名患者(n = 1)和21-29患者(n = 2)。在新生儿重症监护单位中,来自三项研究的可预防的不利药物事件率为每1000次(n = 1)和0.47-14.38,每1000患者 - 天(n = 2)。抗感染剂通常涉及两种环境中的药物误差/可预防的不良药物事件。结论药物错误频繁发生在批判性病儿童患有儿科和新生儿重症监护单位,可能导致患者伤害。鉴定了诸如给药误差和抗感染药物等重要目标,以指导修复干预的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号